Retrospective study to perform the safety and performance of Neohexa-Sirolimus-Eluting Coronary Stent in all patients with coronary artery disease
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: I248- Other forms of acute ischemic heart disease
- Registration Number
- CTRI/2022/10/046402
- Lead Sponsor
- Sahajanand Laser Technology Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Males and Females more than 18 years of age.
2. Subjects who had signed the Hospital Consent Form.
3. The subjects who have been treated with PCI and implanted with Neohexa Drug-Eluting Stent as a part of their treatment of Coronary Artery Disease without any further indication for emergent coronary artery bypass graft surgery
4. Patients who have completed a minimum of 24 months after device implantation (device implanted between 01-01-2017 to 31-12-2019)
Exclusion Criteria
1. Subjects who are treated with stents other than Neohexa stent in the same vessel.
2. Subjects implanted with Neohexa stent after 31-12-2019
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method